Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 7.93 | 8.65 | 3.19 | 10.41 | 11.43 |
| Operating profit | -14.52 | -14.48 | -22.16 | -11.63 | -11.44 |
| Interest | 0.17 | 0.23 | 0.30 | 0.47 | 0.33 |
| Gross profit | -14.04 | -14.45 | -17.41 | -7.30 | -2.92 |
| EPS (Rs) | -0.77 | -1.15 | -1.53 | -0.47 | -0.56 |
Half yearly
results in details
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.64 | 0.26 | 5.06 | 4.81 | 8.85 |
| Stock adjustment | - | - | - | - | - |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 8.56 | 9.16 | 8.30 | 8.27 | 5.90 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | -14.87 | 14.87 | 11.97 | 12.15 |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 13.89 | 28.84 | 2.18 | 1.81 | 4.82 |
| Provisions made | - | - | - | - | - |
| Depreciation | 3.20 | 2.32 | 2.07 | 2.14 | 1.91 |
| Taxation | - | - | - | -3.46 | 2.24 |
| Net profit / loss | -11.25 | -16.77 | -19.48 | -5.98 | -7.07 |
| Extra ordinary item | 6.00 | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 14.54 | 14.54 | 12.73 | 12.73 | 12.73 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -183.15 | -167.32 | -694.70 | -111.77 | -100.06 |
| GPM (%) | -163.93 | -162.10 | -211.04 | -47.98 | -14.38 |
| NPM (%) | -131.26 | -188.18 | -236.12 | -39.29 | -34.83 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis